Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12466)
All Articles published online
|
Publishing Process of This Article
|
Sep 14, 2017 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wei ZQ, Zhang YH, Ke CZ, Chen HX, Ren P, He YL, Hu P, Ma DQ, Luo J, Meng ZJ. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation. World J Gastroenterol 2017; 23(34): 6252-6260 [PMID: PMC5603491 DOI: 10.3748/wjg.v23.i34.6252] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i34/6252.htm |
| Number | Citing Articles |
| 1 |
Zhaoning Wang, Weiwei Wang, Lanfeng Wang. Epigenetic regulation of covalently closed circular DNA minichromosome in hepatitis B virus infection. Biophysics Reports 2020; 6(4): 115 doi: 10.1007/s41048-020-00112-z
|
| 2 |
Sajad Ahmad Bhat, Syed Naqui Kazim. HBV cccDNA─A Culprit and Stumbling Block for the Hepatitis B Virus Infection: Its Presence in Hepatocytes Perplexed the Possible Mission for a Functional Cure. ACS Omega 2022; 7(28): 24066 doi: 10.1021/acsomega.2c02216
|
| 3 |
Archana Sharma, Twinkle Sharma, Rajveer Bhaskar, Monika Ola, Alok Sharma, Prabodh Chander Sharma. Promising Potential of Curcumin and Related Compounds for Antiviral
Drug Discovery. Medicinal Chemistry 2024; 20(6): 597 doi: 10.2174/0115734064277371240325105016
|
| 4 |
Bui Thanh Tung, Nguyen Hong Nhung, Ta Thi Thu Hang, Vu Khanh Linh. Enhancing the Therapeutic Efficacy of Herbal Formulations. Advances in Medical Diagnosis, Treatment, and Care 2021; : 186 doi: 10.4018/978-1-7998-4453-2.ch008
|
| 5 |
Piyanoot Thongsri, Yongyut Pewkliang, Suparerk Borwornpinyo, Adisak Wongkajornsilp, Suradej Hongeng, Khanit Sa-ngiamsuntorn. Curcumin inhibited hepatitis B viral entry through NTCP binding. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-98243-x
|
| 6 |
Yanchao Pan, Zhiyi Ke, Hong Ye, Lina Sun, Xiaoyan Ding, Yun Shen, Runze Zhang, Jing Yuan. Saikosaponin C exerts anti-HBV effects by attenuating HNF1α and HNF4α expression to suppress HBV pgRNA synthesis. Inflammation Research 2019; 68(12): 1025 doi: 10.1007/s00011-019-01284-2
|
| 7 |
Katarzyna Chojnacka, Dawid Skrzypczak, Grzegorz Izydorczyk, Katarzyna Mikula, Daniel Szopa, Anna Witek-Krowiak. Antiviral Properties of Polyphenols from Plants. Foods 2021; 10(10): 2277 doi: 10.3390/foods10102277
|
| 8 |
Feilin Ge, Yan Yang, Zhaofang Bai, Lanlan Si, Xuemei Wang, Jia Yu, Xiaohe Xiao, Yan Liu, Zhigang Ren. The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges. Chinese Medicine 2023; 18(1) doi: 10.1186/s13020-023-00861-2
|
| 9 |
S. Prabhu, K. Kalaimathi, M. Thiruvengadam, M. Ayyanar, K. Shine, S. Amalraj, S. Antony Ceasar, S. Padma Priya, N. Prakash. Antiviral mechanisms of dietary polyphenols: recent developments as antiviral agents and future prospects in combating Nipah virus. Phytochemistry Reviews 2024; doi: 10.1007/s11101-024-10017-1
|
| 10 |
Ee Chee Ren, Nicole Ziyi Zhuo, Zhi Yi Goh, Isabelle Bonne, Benoît Malleret, Hui Ling Ko. cccDNA-Targeted Drug Screen Reveals a Class of Antihistamines as Suppressors of HBV Genome Levels. Biomolecules 2023; 13(10): 1438 doi: 10.3390/biom13101438
|
| 11 |
Deepshikha Shahdeo, Sonu Gandhi. Smart Nanomaterials to Combat the Spread of Viral Infections. 2023; : 323 doi: 10.1016/B978-0-323-99148-3.00004-2
|
| 12 |
Ashif Iqubal, Mohammad K. Iqubal, Musheer Ahmed, Syed E. Haque. Natural Products, a Potential Therapeutic Modality in Management and Treatment of nCoV-19 Infection: Preclinical and Clinical Based Evidence. Current Pharmaceutical Design 2021; 27(9): 1153 doi: 10.2174/1381612827999210111190855
|
| 13 |
Siyu Liu, Jie Liu, Lan He, Liu Liu, Bo Cheng, Fangliang Zhou, Deliang Cao, Yingchun He. A Comprehensive Review on the Benefits and Problems of Curcumin with Respect to Human Health. Molecules 2022; 27(14): 4400 doi: 10.3390/molecules27144400
|
| 14 |
Daniel Stone, Kelly R. Long, Michelle A. Loprieno, Harshana S. De Silva Feelixge, Elizabeth J. Kenkel, R. Matt Liley, Stephen Rapp, Pavitra Roychoudhury, Thuy Nguyen, Laurence Stensland, Rossana Colón-Thillet, Lindsay M. Klouser, Nicholas D. Weber, Connie Le, Jessica Wagoner, Erin A. Goecker, Alvason Zhenhua Li, Karsten Eichholz, Lawrence Corey, D. Lorne Tyrrell, Alexander L. Greninger, Meei-Li Huang, Stephen J. Polyak, Martine Aubert, John E. Sagartz, Keith R. Jerome. CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice. Molecular Therapy - Methods & Clinical Development 2021; 20: 258 doi: 10.1016/j.omtm.2020.11.014
|
| 15 |
Kruthika Iyer, Zhonghao Yan, Susan R. Ross. Entry inhibitors as arenavirus antivirals. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1382953
|
| 16 |
Dimas Praditya, Lisa Kirchhoff, Janina Brüning, Heni Rachmawati, Joerg Steinmann, Eike Steinmann. Anti-infective Properties of the Golden Spice Curcumin. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.00912
|
| 17 |
Zhi Yi Goh, Ee Chee Ren, Hui Ling Ko. Intracellular interferon signalling pathways as potential regulators of covalently closed circular DNA in the treatment of chronic hepatitis B. World Journal of Gastroenterology 2021; 27(14): 1369-1391 doi: 10.3748/wjg.v27.i14.1369
|
| 18 |
Laura Marinela Ailioaie, Gerhard Litscher. Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(19): 7150 doi: 10.3390/ijms21197150
|
| 19 |
Ananya Das Mahapatra, Indrani Paul, Sanjukta Dasgupta, Oliva Roy, Srinjoy Sarkar, Tusha Ghosh, Sayantan Basu, Debprasad Chattopadhyay. Antiviral Potential and In Silico Insights of Polyphenols as Sustainable Phytopharmaceuticals: A Comprehensive Review. Chemistry & Biodiversity 2024; doi: 10.1002/cbdv.202401913
|
| 20 |
Alexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman. Anti-hepatitis B virus activity of food nutrients and potential mechanisms of action. Annals of Hepatology 2023; 28(4): 100766 doi: 10.1016/j.aohep.2022.100766
|
| 21 |
Abdollah Ardebili, Mohammad Hassan Pouriayevali, Sahar Aleshikh, Marziyeh Zahani, Mehdi Ajorloo, Ahdieh Izanloo, Abolghasem Siyadatpanah, Hadi Razavi Nikoo, Polrat Wilairatana, Henrique Douglas Melo Coutinho. Antiviral Therapeutic Potential of Curcumin: An Update. Molecules 2021; 26(22): 6994 doi: 10.3390/molecules26226994
|
| 22 |
Ye Htut Linn, Win Win Ei, Lwin Mon Mon Myint, Khin Maung Lwin. Anti-hepatitis B activities of Myanmar medicinal plants: a narrative review of current evidence. VirusDisease 2021; 32(3): 446 doi: 10.1007/s13337-021-00714-2
|
| 23 |
Long Feng, Wu-Hao Lu, Qing-Ya Li, Hai-Yan Zhang, Li-Ran Xu, Wen-Qiao Zang, Wen-Tao Guo, Yan-Fang Li, Wen-Jin Zheng, Yu-Xuan Geng, Qing Li, Yu-Han Liu. Curcuma Longa Induces the Transcription Factor FOXP3 to Downregulate Human Chemokine CCR5 Expression and Inhibit HIV-1 Infection. The American Journal of Chinese Medicine 2023; 51(05): 1189 doi: 10.1142/S0192415X23500544
|
| 24 |
Sanjit Boora, Vikrant Sharma, Sulochana Kaushik, Ajoy Varma Bhupatiraju, Sandeep Singh, Samander Kaushik. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem. Brazilian Journal of Microbiology 2023; 54(2): 679 doi: 10.1007/s42770-023-00970-y
|
| 25 |
Rosita Gabbianelli, Ehud Shahar, Gaia de Simone, Chiara Rucci, Laura Bordoni, Giulia Feliziani, Fanrui Zhao, Marta Ferrati, Filippo Maggi, Eleonora Spinozzi, Jamal Mahajna. Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents. Nutrients 2023; 15(22): 4719 doi: 10.3390/nu15224719
|
| 26 |
Alicja Warowicka, Robert Nawrot, Anna Goździcka-Józefiak. Antiviral activity of berberine. Archives of Virology 2020; 165(9): 1935 doi: 10.1007/s00705-020-04706-3
|
| 27 |
Ying-Qi Wu, Tong Tong. Curcumae Rhizoma: A botanical drug against infectious diseases. Frontiers in Pharmacology 2023; 13 doi: 10.3389/fphar.2022.1015098
|
| 28 |
Xuelian Meng, Xiangwei Wang, Xueliang Zhu, Rui Zhang, Zhidong Zhang, Yuefeng Sun. Quantitative analysis of acetylation in peste des petits ruminants virus-infected Vero cells. Virology Journal 2023; 20(1) doi: 10.1186/s12985-023-02200-1
|
| 29 |
João Batista de Andrade Neto, Vitória Pessoa de Farias Cabral, Lavouisier Frankilin Brito Nogueira, Cecília Rocha da Silva, Lívia Gurgel do Amaral Valente Sá, Anderson Ramos da Silva, Wildson Max Barbosa da Silva, Jacilene Silva, Emmanuel Silva Marinho, Bruno Coelho Cavalcanti, Manoel Odorico de Moraes, Hélio Vitoriano Nobre Júnior. Anti-MRSA activity of curcumin in planktonic cells and biofilms and determination of possible action mechanisms. Microbial Pathogenesis 2021; 155: 104892 doi: 10.1016/j.micpath.2021.104892
|
| 30 |
Pei He, Peixin Zhang, Yaping Fang, Ning Han, Wensu Yang, Zhaoxin Xia, Yi Zhu, Zhenhua Zhang, Jilu Shen. The role of HBV cccDNA in occult hepatitis B virus infection. Molecular and Cellular Biochemistry 2023; 478(10): 2297 doi: 10.1007/s11010-023-04660-z
|
| 31 |
Tingting Qin, Xiuying Chen, Jiahui Meng, Qianqian Guo, Shan Xu, Shanshan Hou, Ziqiao Yuan, Wenzhou Zhang. The role of curcumin in the liver-gut system diseases: from mechanisms to clinical therapeutic perspective. Critical Reviews in Food Science and Nutrition 2024; 64(24): 8822 doi: 10.1080/10408398.2023.2204349
|
| 32 |
Youlu Pan, Heye Xia, Yanwen He, Shenxin Zeng, Zhengrong Shen, Wenhai Huang. The progress of molecules and strategies for the treatment of HBV infection. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1128807
|
| 33 |
Vinod S. Ipar, Anisha Dsouza, Padma V. Devarajan. Enhancing Curcumin Oral Bioavailability Through Nanoformulations. European Journal of Drug Metabolism and Pharmacokinetics 2019; 44(4): 459 doi: 10.1007/s13318-019-00545-z
|
| 34 |
Zhiying Wang, Xiaojing Cai, Zhiyuan Ren, Yi Shao, Yongkang Xu, Lian Fu, Yan Zhu. Piceatannol as an Antiviral Inhibitor of PRV Infection In Vitro and In Vivo. Animals 2023; 13(14): 2376 doi: 10.3390/ani13142376
|
| 35 |
Xiaoqing Tan, Linting Xun, Qi Yin, Chaohui Chen, Tao Zhang, Tao Shen. Epigenetic Modifications in HBV‐Related Hepatocellular Carcinoma. Journal of Viral Hepatitis 2025; 32(2) doi: 10.1111/jvh.14044
|
| 36 |
Shrinjana Dhar, Pritha Bhattacharjee. Promising role of curcumin against viral diseases emphasizing COVID-19 management: A review on the mechanistic insights with reference to host-pathogen interaction and immunomodulation. Journal of Functional Foods 2021; 82: 104503 doi: 10.1016/j.jff.2021.104503
|
| 37 |
An-Qi Zhuang, Yan Chen, Shan-Mei Chen, Wen-Cheng Liu, Yao Li, Wen-Jie Zhang, Yi-Hang Wu. Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA. Viruses 2023; 15(12): 2315 doi: 10.3390/v15122315
|
| 38 |
Sita Sharan Patel, Ashish Acharya, R. S. Ray, Ritesh Agrawal, Ramsaneh Raghuwanshi, Priyal Jain. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease. Critical Reviews in Food Science and Nutrition 2020; 60(6): 887 doi: 10.1080/10408398.2018.1552244
|
| 39 |
|
| 40 |
Wanrong Song, Xizhao Chen, Chongshan Dai, Degui Lin, Xuelin Pang, Di Zhang, Gang Liu, Yipeng Jin, Jiahao Lin. Comparative Study of Preparation, Evaluation, and Pharmacokinetics in Beagle Dogs of Curcumin β-Cyclodextrin Inclusion Complex, Curcumin Solid Dispersion, and Curcumin Phospholipid Complex. Molecules 2022; 27(9): 2998 doi: 10.3390/molecules27092998
|
| 41 |
Lei Guo, Hongbo Li, Tianli Fan, Yanli Ma, Lili Wang. Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma. Life Sciences 2021; 279: 119359 doi: 10.1016/j.lfs.2021.119359
|
| 42 |
Jinlai Wei, Xichuan Deng, Wenying Dai, Lingxin Xie, Guangyuan Zhang, Xinyue Fan, Xinyue Li, Zhixing Jin, Qin Xiao, Tingting Chen. Desmethoxycurcumin aids IFNα’s anti-HBV activity by antagonising CRYAB reduction and stabilising IFNAR1 protein. Journal of Drug Targeting 2023; 31(9): 976 doi: 10.1080/1061186X.2023.2273200
|
| 43 |
Xin Tan, Yu Xiang, Jianyou Shi, Lu Chen, Dongke Yu. Targeting NTCP for liver disease treatment: A promising strategy. Journal of Pharmaceutical Analysis 2024; 14(9): 100979 doi: 10.1016/j.jpha.2024.100979
|
| 44 |
Anjing Zhu, Xinzhong Liao, Shuang Li, Hang Zhao, Limin Chen, Min Xu, Xiaoqiong Duan. HBV cccDNA and Its Potential as a Therapeutic Target. Journal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2018.00054
|
| 45 |
Mingzhu Liu, Hehe Xiao, Qin Zhang, Siting Wu, Dedi Fazriansyah Putra, Xiangying Xiong, Mingzhu Xu, Lanfang Dong, Siqiao Li, Qing Yu, Pengfei Li.
Antiviral abilities of
Curcuma kwangsiensis
ingredients against grouper iridoviral infection in vitro and in vivo
. Aquaculture Research 2020; 51(1): 351 doi: 10.1111/are.14382
|
| 46 |
Umair Younas, Sana Tehseen, Fazlullah Khan, Kamal Niaz. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. 2021; : 19 doi: 10.1016/B978-0-12-816488-4.00012-7
|
| 47 |
Roberto Arrigoni, Andrea Ballini, Emilio Jirillo, Luigi Santacroce. Current View on Major Natural Compounds Endowed with Antibacterial and Antiviral Effects. Antibiotics 2024; 13(7): 603 doi: 10.3390/antibiotics13070603
|
| 48 |
Guqi Wang, Peng Liang, Ping Li, Yang Hui Tan, Herbert L. Bonkovsky. The Role of Traditional Chinese Medicines (TCM) and Other Complementary and Alternative Medicines (CAM) in the Management of Chronic Hepatitis B. Current Hepatology Reports 2019; 18(3): 316 doi: 10.1007/s11901-019-00480-2
|
| 49 |
Miao Li, Zheng-Gang Ren, Jie-Feng Cui. Advances in understanding of mechanism of anti-hepatocellular carcinoma effects of curcumin. World Chinese Journal of Digestology 2019; 27(17): 1043 doi: 10.11569/wcjd.v27.i17.1043
|
| 50 |
Chukuka S. Enwemeka, Violet V. Bumah, J. Chris Castel, Samantha L. Suess. Pulsed blue light, saliva and curcumin significantly inactivate human coronavirus. Journal of Photochemistry and Photobiology B: Biology 2022; 227: 112378 doi: 10.1016/j.jphotobiol.2021.112378
|
| 51 |
Rajeshwari Singh, Sumeet Goel, Pascale Bourgeade, Lotfi Aleya, Devesh Tewari. Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19. Environmental Science and Pollution Research 2021; 28(40): 55925 doi: 10.1007/s11356-021-16280-5
|
| 52 |
Claryssa Bianca, Elizabeth Sidhartha, Claudio Tiribelli, Korri Elvanita El-Khobar, Caecilia H C Sukowati. Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA . World Journal of Hepatology 2022; 14(5): 866-884 doi: 10.4254/wjh.v14.i5.866
|
| 53 |
Ana Maria Ortega-Prieto, Catherine Cherry, Harry Gunn, Marcus Dorner. In Vivo Model Systems for Hepatitis B Virus Research. ACS Infectious Diseases 2019; 5(5): 688 doi: 10.1021/acsinfecdis.8b00223
|
| 54 |
Tae Kyung Hyun. Roles of polyphenols as dietary epigenetic modulators. Minerva Biotecnologica 2019; 31(2) doi: 10.23736/S1120-4826.19.02522-9
|
| 55 |
Yaw-Syan Fu, Ting-Hsu Chen, Lebin Weng, Liyue Huang, Dong Lai, Ching-Feng Weng. Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential. Biomedicine & Pharmacotherapy 2021; 141: 111888 doi: 10.1016/j.biopha.2021.111888
|
| 56 |
Carmen de la Rocha, Fabiola E. Tristan-Flores, Guillermo A. Silva-Martínez, Lucrecia Carrera-Quintanar, Fabiola Márquez-Sandoval. Pathogens Associated with the Development of Cancer in Humans. 2024; : 459 doi: 10.1007/978-3-031-62558-9_20
|
| 57 |
Zhitao Zhang, Yanzhen Han, Guangxin Sun, Xiaohong Liu, Xiaoyan Jia, Xiangjun Yu. RETRACTED ARTICLE: MicroRNA-325-3p inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma by down-regulation of aquaporin 5. Cellular & Molecular Biology Letters 2019; 24(1) doi: 10.1186/s11658-019-0137-1
|
| 58 |
Shahin Homaeigohar, Qiqi Liu, Danial Kordbacheh. Biomedical Applications of Antiviral Nanohybrid Materials Relating to the COVID-19 Pandemic and Other Viral Crises. Polymers 2021; 13(16): 2833 doi: 10.3390/polym13162833
|
| 59 |
Spices and herbs: Potential antiviral preventives and immunity boosters duringCOVID‐19. Phytotherapy Research 2021; 35(5): 2745 doi: 10.1002/ptr.7019
|
| 60 |
Mi-Xia CAO, Xin-Rui WANG, Wen-Yue HU, Dan YIN, Chun-Zhi REN, Si-Yu CHEN, Mei-Ling YU, Ying-Yi WEI, Ting-Jun HU. Regulatory effect of <i>Panax notoginseng</i> saponins on the oxidative stress and histone acetylation induced by porcine circovirus type 2. Journal of Veterinary Medical Science 2022; 84(4): 600 doi: 10.1292/jvms.21-0126
|
| 61 |
Samah A Loutfy, Mostafa H Elberry, Khaled Yehia Farroh, Hossam Taha Mohamed, Aya A Mohamed, ElChaimaa B Mohamed, Ahmed Hassan Ibrahim Faraag, Shaker A Mousa. <p>Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines</p>. International Journal of Nanomedicine 2020; : 2699 doi: 10.2147/IJN.S241702
|
| 62 |
Xinping Ma, Yuan Li, Huihui Zhu, Kai Lu, Yingli Huang, Xiaofang Li, Shuangyin Han, Hui Ding, Suofeng Sun. ENPP1 inhibits the transcription activity of the hepatitis B virus pregenomic promoter by upregulating the acetylation of LMNB1. Archives of Virology 2024; 169(2) doi: 10.1007/s00705-023-05949-6
|
| 63 |
Anjar Hermadi Saputro, Aluicia Anita Artarini, Daryono Hadi Tjahjono, Sophi Damayanti. The long and stumble way to find potential active compounds from plants for defeating hepatitis B and C: review. Pharmacia 2022; 69(3): 699 doi: 10.3897/pharmacia.69.e85160
|
| 64 |
Siwei Chen, Lan Zhang, Yi Chen, Leilei Fu. Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential. Journal of Medicinal Chemistry 2022; 65(19): 12546 doi: 10.1021/acs.jmedchem.2c01097
|
| 65 |
Shousheng Liu, Yongning Xin. HBV cccDNA: The Stumbling Block for Treatment of HBV Infection. Journal of Clinical and Translational Hepatology 2019; 7(3): 1 doi: 10.14218/JCTH.2019.00047
|
| 66 |
Pankaj Kumar Rai, Zeba Mueed, Abhiroop Chowdhury, Ravi Deval, Dinesh Kumar, Mohammad A. Kamal, Yogeshwar Singh Negi, Shubhra Pareek, Hemlata Sharma, Nitesh Kumar Poddar. Current Overviews on COVID-19 Management Strategies. Current Pharmaceutical Biotechnology 2022; 23(3): 361 doi: 10.2174/1389201022666210509022313
|